Ticker Details
GeneDx Holdings Corp.
IPO Date:	November 2, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$1.4B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.71 | 4.41%
Avg Daily Range (30 D):	$1.69 | 3.24%
Avg Daily Range (90 D):	$2.69 | 3.61%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	1.44M
Avg Daily Volume (90 D):	.93M

Trade Size
Avg Trade Size (Sh.):	77
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	1,181
Avg Institutional Trade:	$3.34M
Avg Institutional Trade (30 D):	$2.57M
Avg Institutional Trade (90 D):	$3.13M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.98M
Avg Closing Trade (30 D):	$4.67M
Avg Closing Trade (90 D):	$5.6M
Avg Closing Volume:	63.35K

News

May 23, 2026 @ 8:17 PM This Healthcare Investor Added $43 Million to a Ge... Source: Jonathan Ponciano

May 21, 2026 @ 2:23 PM Is GeneDx Stock a Buys After a Company Director Pu... Source: Robert Izquierdo

May 19, 2026 @ 10:22 PM Bragar Eagel & Squire, P.C. is Investigating GeneD... Source: Bragar Eagel & Squire, P.C.

May 18, 2026 @ 11:00 PM WGS SHAREHOLDER ALERT: Investors Encouraged to Con... Source: Kirby Mcinerney Llp

May 13, 2026 @ 11:00 PM WGS SHAREHOLDER ALERT: Investors Encouraged to Con... Source: Kirby Mcinerney Llp

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.16	$-.61	$-.73
Diluted EPS	$-2.16	$-.61	$-.73
Revenue	$102.25M	$120.99M	$427.54M
Gross Profit	$68.21M	$84.27M	$298.17M
Net Income / Loss	$-63.32M	$-17.67M	$-21.02M
Operating Income / Loss	$-57.47M	$-14.24M	$-13.08M
Cost of Revenue	$34.04M	$36.72M	$129.37M
Net Cash Flow	$-11.07M	$9.03M	$19.79M
PE Ratio

Splits
May 04, 2023	1:33